Trial Profile
PROOF OF CONCEPT STUDY OF HYQVIA IN PATIENTS WITH IMMUNOGLOBULIN DEFICIENCY AND RECURRENT INFECTIONS WITH CHRONIC FATIGUE SYNDROME Proof of Concept Studie mit HyQvia bei Patienten mit Immunglobinmangel und wiederholten Infektionen bei Chronischem Fatigue Syndrom (CFS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2022
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Chronic fatigue syndrome; Immunodeficiency disorders
- Focus Proof of concept; Therapeutic Use
- 05 Jun 2022 Status changed from recruiting to completed.
- 06 Jan 2017 New trial record